Catalyst Wire Dossier Catalyst Wire Dossier

PRN1008

· Principia Biopharma (a Sanofi company)
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PRN1008, covering 2022-09-21 to 2023-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris [Phase 2]

See pricing